Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2024

06-01-2024 | Eosinophilic Esophagitis | Original Article

Vitamin D Levels as a Potential Modifier of Eosinophilic Esophagitis Severity in Adults

Authors: Brenderia A. Cameron, Carlton W. Anderson, Elizabeth T. Jensen, Evan S. Dellon

Published in: Digestive Diseases and Sciences | Issue 4/2024

Login to get access

Abstract

Background

Vitamin D deficiency is associated with atopic and immune-mediated diseases but has not been extensively assessed in eosinophilic esophagitis (EoE). We aimed to assess if vitamin D levels in newly diagnosed EoE patients were lower than in non-EoE controls and examine levels in relation to EoE clinical features.

Methods

This secondary analysis of a prospective cohort study used data and biosamples from adults who underwent outpatient esophagogastroduodenoscopy. Before each procedure, blood was obtained and stored at -80oC. Serum 25-hydroxy-vitamin D3 (25(OH)D3) was measured by ELISA. Levels for cases and controls were compared at baseline. Within cases, 25(OH)D3 levels were compared for clinical, endoscopic, and histologic measures.

Results

We analyzed 40 EoE and 40 non-EoE controls. Mean serum 25(OH)D3 level was slightly lower in EoE patients than controls (30.9 ± 15.3 ng/mL vs. 35.9 ± 15.4; p = 0.15). After controlling for age, sex, and race, adjusted levels were 10.8 ng/mL lower in EoE patients (95% CI: -19.0, -2.5), but 25(OH)D3 deficiency (< 20ng/mL) was similar in cases and controls (20% vs. 15%; p = 0.56). Levels of 25(OH)D3 were not associated with differences in clinical or endoscopic features of EoE, and EREFS and eosinophil counts did not significantly correlate with 25(OH)D3 levels (R of -0.28 [p = 0.08] and − 0.01 [p = 0.93], respectively). 25(OH)D3 levels were lower in EoE cases with lamina propria fibrosis (23.2 ± 9.6 vs. 45.0 ± 17.7; p = 0.03).

Conclusions

After adjusting for age, sex, and race, 25(OH)D3 levels were lower in EoE cases than controls, but deficiency was not common. 25(OH)D3 levels were generally similar across most EoE disease features.
Literature
1.
go back to reference Hahn JW, Lee K, Shin JL, and e. al., Global Incidence and Prevalence of Eosinophilic Esophagitis Clin Gastroenterol hepatol, 1976–2022. Hahn JW, Lee K, Shin JL, and e. al., Global Incidence and Prevalence of Eosinophilic Esophagitis Clin Gastroenterol hepatol, 1976–2022.
2.
go back to reference Dellon, E.S. and C.A. Liacouras, Advances in clinical management of eosinophilic esophagitis. Gastroenterology, 2014. 147(6): p. 1238–54.CrossRefPubMed Dellon, E.S. and C.A. Liacouras, Advances in clinical management of eosinophilic esophagitis. Gastroenterology, 2014. 147(6): p. 1238–54.CrossRefPubMed
3.
go back to reference Dellon, E.S. and I. Hirano, Epidemiology and Natural History of Eosinophilic Esophagitis. Gastroenterology, 2018. 154(2): p. 319–332.e3.CrossRefPubMed Dellon, E.S. and I. Hirano, Epidemiology and Natural History of Eosinophilic Esophagitis. Gastroenterology, 2018. 154(2): p. 319–332.e3.CrossRefPubMed
4.
go back to reference Dellon, E.S., et al., A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc, 2014. 79(4): p. 577 – 85.e4. Dellon, E.S., et al., A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc, 2014. 79(4): p. 577 – 85.e4.
5.
go back to reference Kim, H.P., R.B. Vance, N.J. Shaheen, and E.S. Dellon, The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol, 2012. 10(9): p. 988 – 96.e5. Kim, H.P., R.B. Vance, N.J. Shaheen, and E.S. Dellon, The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol, 2012. 10(9): p. 988 – 96.e5.
6.
go back to reference Dellon, E.S., et al., Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference Gastroenterology, 2018. 155(4): p. 1022–1033.e10. Dellon, E.S., et al., Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference Gastroenterology, 2018. 155(4): p. 1022–1033.e10.
7.
go back to reference Bonis, P.A., Putting the puzzle together: epidemiological and clinical clues in the etiology of eosinophilic esophagitis Immunol Allergy Clin North Am, 2009. 29(1): p. 41–52, viii. Bonis, P.A., Putting the puzzle together: epidemiological and clinical clues in the etiology of eosinophilic esophagitis Immunol Allergy Clin North Am, 2009. 29(1): p. 41–52, viii.
8.
go back to reference Dellon, E.S., et al., The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark. Aliment Pharmacol Ther, 2015. 41(7): p. 662–70.CrossRefPubMedPubMedCentral Dellon, E.S., et al., The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark. Aliment Pharmacol Ther, 2015. 41(7): p. 662–70.CrossRefPubMedPubMedCentral
9.
go back to reference Giriens, B., et al., Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993–2013: a population-based study. Allergy, 2015. 70(12): p. 1633–9.CrossRefPubMed Giriens, B., et al., Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993–2013: a population-based study. Allergy, 2015. 70(12): p. 1633–9.CrossRefPubMed
10.
go back to reference O’Shea, K.M., et al., Pathophysiology of Eosinophilic Esophagitis. Gastroenterology, 2018. 154(2): p. 333–345.CrossRefPubMed O’Shea, K.M., et al., Pathophysiology of Eosinophilic Esophagitis. Gastroenterology, 2018. 154(2): p. 333–345.CrossRefPubMed
11.
go back to reference Bredenoord, A.J., Eosinophilic esophagitis and the promise of vitamin D. Gut, 2023. 72(5): p. 812–813.CrossRefPubMed Bredenoord, A.J., Eosinophilic esophagitis and the promise of vitamin D. Gut, 2023. 72(5): p. 812–813.CrossRefPubMed
12.
go back to reference Solidoro, P., et al., Asthmatic Patients with Vitamin D Deficiency have Decreased Exacerbations after Vitamin Replacement. Nutrients, 2017. 9(11). Solidoro, P., et al., Asthmatic Patients with Vitamin D Deficiency have Decreased Exacerbations after Vitamin Replacement. Nutrients, 2017. 9(11).
13.
go back to reference Agarwal, S., S.N. Singh, R. Kumar, and R. Sehra, Vitamin D: A Modulator of Allergic Rhinitis. Indian J Otolaryngol Head Neck Surg, 2019. 71(Suppl 3): p. 2225–2230.CrossRefPubMedPubMedCentral Agarwal, S., S.N. Singh, R. Kumar, and R. Sehra, Vitamin D: A Modulator of Allergic Rhinitis. Indian J Otolaryngol Head Neck Surg, 2019. 71(Suppl 3): p. 2225–2230.CrossRefPubMedPubMedCentral
15.
go back to reference Teixeira, T.L., et al., CASE-CONTROL STUDY ON VITAMIN D STATUS IN CHILDREN AND ADOLESCENTS WITH EOSINOPHILIC ESOPHAGITIS. Arq Gastroenterol, 2020. 57(4): p. 409–415.CrossRefPubMed Teixeira, T.L., et al., CASE-CONTROL STUDY ON VITAMIN D STATUS IN CHILDREN AND ADOLESCENTS WITH EOSINOPHILIC ESOPHAGITIS. Arq Gastroenterol, 2020. 57(4): p. 409–415.CrossRefPubMed
16.
go back to reference Brusilovsky, M., et al., Vitamin D receptor and STAT6 interactome governs oesophageal epithelial barrier responses to IL-13 signalling. Gut, 2023. 72(5): p. 834–845.CrossRefPubMed Brusilovsky, M., et al., Vitamin D receptor and STAT6 interactome governs oesophageal epithelial barrier responses to IL-13 signalling. Gut, 2023. 72(5): p. 834–845.CrossRefPubMed
17.
go back to reference Cui, A., et al., Prevalence, trend, and predictor analyses of vitamin D deficiency in the US population, 2001–2018. Front Nutr, 2022. 9: p. 965376.CrossRefPubMedPubMedCentral Cui, A., et al., Prevalence, trend, and predictor analyses of vitamin D deficiency in the US population, 2001–2018. Front Nutr, 2022. 9: p. 965376.CrossRefPubMedPubMedCentral
18.
go back to reference Dellon, E.S., et al., A Clinical Prediction Tool Identifies Cases of Eosinophilic Esophagitis Without Endoscopic Biopsy: A Prospective Study. Am J Gastroenterol, 2015. 110(9): p. 1347–54.CrossRefPubMedPubMedCentral Dellon, E.S., et al., A Clinical Prediction Tool Identifies Cases of Eosinophilic Esophagitis Without Endoscopic Biopsy: A Prospective Study. Am J Gastroenterol, 2015. 110(9): p. 1347–54.CrossRefPubMedPubMedCentral
19.
go back to reference Dellon, E.S., et al., Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study. Am J Gastroenterol, 2015. 110(6): p. 821–7.CrossRefPubMedPubMedCentral Dellon, E.S., et al., Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study. Am J Gastroenterol, 2015. 110(6): p. 821–7.CrossRefPubMedPubMedCentral
20.
go back to reference Eluri, S., et al., Heartburn and dyspepsia symptom severity improves after treatment and correlates with histology in adults with eosinophilic esophagitis. Dis Esophagus, 2019. 32(9). Eluri, S., et al., Heartburn and dyspepsia symptom severity improves after treatment and correlates with histology in adults with eosinophilic esophagitis. Dis Esophagus, 2019. 32(9).
21.
go back to reference Tappata, M., et al., Association of mast cells with clinical, endoscopic, and histologic findings in adults with eosinophilic esophagitis. Allergy, 2018. 73(10): p. 2088–2092.CrossRefPubMed Tappata, M., et al., Association of mast cells with clinical, endoscopic, and histologic findings in adults with eosinophilic esophagitis. Allergy, 2018. 73(10): p. 2088–2092.CrossRefPubMed
22.
go back to reference Reed, C.C., et al., Optimal Histologic Cutpoints for Treatment Response in Patients With Eosinophilic Esophagitis: Analysis of Data From a Prospective Cohort Study. Clin Gastroenterol Hepatol, 2018. 16(2): p. 226–233.e2.CrossRefPubMed Reed, C.C., et al., Optimal Histologic Cutpoints for Treatment Response in Patients With Eosinophilic Esophagitis: Analysis of Data From a Prospective Cohort Study. Clin Gastroenterol Hepatol, 2018. 16(2): p. 226–233.e2.CrossRefPubMed
23.
go back to reference Liacouras, C.A., et al., Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol, 2011. 128(1): p. 3–20.e6; quiz 21 – 2.CrossRefPubMed Liacouras, C.A., et al., Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol, 2011. 128(1): p. 3–20.e6; quiz 21 – 2.CrossRefPubMed
24.
go back to reference Dellon, E.S., et al., ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol, 2013. 108(5): p. 679 – 92; quiz 693. Dellon, E.S., et al., ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol, 2013. 108(5): p. 679 – 92; quiz 693.
25.
go back to reference Hirano, I., et al., Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut, 2013. 62(4): p. 489–95.CrossRefPubMed Hirano, I., et al., Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut, 2013. 62(4): p. 489–95.CrossRefPubMed
26.
go back to reference Dellon, E.S., et al., Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment. Clin Gastroenterol Hepatol, 2016. 14(1): p. 31–9.CrossRefPubMed Dellon, E.S., et al., Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment. Clin Gastroenterol Hepatol, 2016. 14(1): p. 31–9.CrossRefPubMed
27.
go back to reference Dellon, E.S., et al., The esophageal biopsy “pull” sign: a highly specific and treatment-responsive endoscopic finding in eosinophilic esophagitis (with video) Gastrointest Endosc, 2016. 83(1): p. 92–100. Dellon, E.S., et al., The esophageal biopsy “pull” sign: a highly specific and treatment-responsive endoscopic finding in eosinophilic esophagitis (with video) Gastrointest Endosc, 2016. 83(1): p. 92–100.
28.
go back to reference Dellon, E.S., et al., Inter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophilia. Dig Dis Sci, 2010. 55(7): p. 1940–9.CrossRefPubMed Dellon, E.S., et al., Inter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophilia. Dig Dis Sci, 2010. 55(7): p. 1940–9.CrossRefPubMed
29.
go back to reference Rusin, S., et al., Determination of esophageal eosinophil counts and other histologic features of eosinophilic esophagitis by pathology trainees is highly accurate. Hum Pathol, 2017. 62: p. 50–55.CrossRefPubMed Rusin, S., et al., Determination of esophageal eosinophil counts and other histologic features of eosinophilic esophagitis by pathology trainees is highly accurate. Hum Pathol, 2017. 62: p. 50–55.CrossRefPubMed
30.
go back to reference Reed, C.C., W.A. Wolf, C.C. Cotton, and E.S. Dellon, A visual analogue scale and a Likert scale are simple and responsive tools for assessing dysphagia in eosinophilic oesophagitis. Aliment Pharmacol Ther, 2017. 45(11): p. 1443–1448.CrossRefPubMedPubMedCentral Reed, C.C., W.A. Wolf, C.C. Cotton, and E.S. Dellon, A visual analogue scale and a Likert scale are simple and responsive tools for assessing dysphagia in eosinophilic oesophagitis. Aliment Pharmacol Ther, 2017. 45(11): p. 1443–1448.CrossRefPubMedPubMedCentral
31.
go back to reference Drown, D.J., Vitamin D deficiency in the United States: a growing epidemic with serious health consequences. Prog Cardiovasc Nurs, 2009. 24(3): p. 117–8.CrossRefPubMed Drown, D.J., Vitamin D deficiency in the United States: a growing epidemic with serious health consequences. Prog Cardiovasc Nurs, 2009. 24(3): p. 117–8.CrossRefPubMed
32.
go back to reference Caballero-García, A., et al., The Immunomodulatory Function of Vitamin D, with Particular Reference to SARS-CoV-2. Medicina (Kaunas), 2021. 57(12). Caballero-García, A., et al., The Immunomodulatory Function of Vitamin D, with Particular Reference to SARS-CoV-2. Medicina (Kaunas), 2021. 57(12).
33.
go back to reference Sadarangani, S.P., J.A. Whitaker, and G.A. Poland, “Let there be light”: the role of vitamin D in the immune response to vaccines. Expert Rev Vaccines, 2015. 14(11): p. 1427–40.CrossRefPubMedPubMedCentral Sadarangani, S.P., J.A. Whitaker, and G.A. Poland, “Let there be light”: the role of vitamin D in the immune response to vaccines. Expert Rev Vaccines, 2015. 14(11): p. 1427–40.CrossRefPubMedPubMedCentral
34.
go back to reference Cantorna, M.T., Why do T cells express the vitamin D receptor? Ann N Y Acad Sci, 2011. 1217: p. 77–82.CrossRefPubMed Cantorna, M.T., Why do T cells express the vitamin D receptor? Ann N Y Acad Sci, 2011. 1217: p. 77–82.CrossRefPubMed
35.
36.
go back to reference Ma, D. and L. Peng, Vitamin D and pulmonary fibrosis: a review of molecular mechanisms. Int J Clin Exp Pathol, 2019. 12(9): p. 3171–3178.PubMedPubMedCentral Ma, D. and L. Peng, Vitamin D and pulmonary fibrosis: a review of molecular mechanisms. Int J Clin Exp Pathol, 2019. 12(9): p. 3171–3178.PubMedPubMedCentral
Metadata
Title
Vitamin D Levels as a Potential Modifier of Eosinophilic Esophagitis Severity in Adults
Authors
Brenderia A. Cameron
Carlton W. Anderson
Elizabeth T. Jensen
Evan S. Dellon
Publication date
06-01-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08264-x

Other articles of this Issue 4/2024

Digestive Diseases and Sciences 4/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.